Generika Drugstore, Valenzuela City launch country’s first citywide PhilHealth GAMOT Partnership

Generika Drugstore and the City Government of Valenzuela launched the very first partnership between a nationwide drugstore chain and a local government unit (LGU) providing an entire city access to essential medicines for free under the Philippine Health Insurance Corporation (PhilHealth)’s Guaranteed and Accessible Medications for Outpatient Treatment (GAMOT) Program.

On Friday, about 600 Valenzuela City residents underwent medical consultation from PhilHealth’s Yaman ng Kalusugan Program (YAKAP)-accredited doctors from the City Health Department and received prescribed medicines onsite for free thru PhilHealth’s GAMOT from Generika Drugstore.

“This is ginhawa to the fullest. Working with the City Government of Valenzuela allows us to showcase our Ginhawang Generika promise while serving our fellow Filipinos,” said Adrian Gino Guinto, President and Chief Executive Officer of Generika Drugstore.

Under this partnership, YAKAP-registered residents of Valenzuela City who have undergone medical consultation in YAKAP-accredited clinics and have prescriptions with unique security codes (UPSC) can claim up to P20,000 worth of essential medicines in any of the ten (10) Generika Drugstore branches in Valenzuela City that have been accredited by PhilHealth as GAMOT Providers:

• Dalandanan

• Parada Capt. Cruz

• Bagbaguin Mariano

• Gen. T. De Leon

• Malinta Santiago

• Maysan Tongco

• Paso de Blas

• Pio St. Marulas

• Poblacion 1 MH Del Pilar (Polo)

• Veinte Reales

Because of up to 85% savings that consumers can get for buying Actimed Quality Generics, YAKAP beneficiaries can buy significantly more medicines—enough to complete their doctors’ prescriptions.

“We are honored to be part of this pioneering partnership. We thank Generika Drugstore and PhilHealth for helping us make Valenzuela City a truly progressive city where no Valenzuelano family gets left behind,” said City Mayor Wes Gatchalian.

For his part, PhilHealth President and CEO Dr. Edwin Mercado highlighted the importance of multi-stakeholder partnerships in ensuring the success of the government’s flagship health programs. “With active partners like Generika Drugstore and Valenzuela City, Filipinos can rest assured that PhilHealth can help, wherever and whenever they need it,” said Dr. Mercado.

In turn, Guinto thanked partners and stakeholders whose openness and collaboration were key in building the partnership. “With the AC Health group’s support, we invite like-minded local chief executives to follow suit and together, let’s push ginhawa within closer reach of Filipino families,” he added.

To date, 171 Generika Drugstore branches nationwide have been accredited as GAMOT providers. For the full list, click here. 

1Life, Inc. Records 1 Million Patients as its Tech-Enabled Healthcare Network Drives Early Detection and Preventive Care

12 December 2025, Philippines – 1Life, Inc., a Filipino healthcare tech company committed to social impact, has served one million patients through two years of field hospital services and nationwide deployment of its tech-enabled model for primary care. The milestone underscores 1Life’s mission to improve health outcomes and protect Filipinos from preventable illnesses through early detection and timely intervention.

By bringing healthcare directly to local communities, the company delivered fast, connected healthcare across more than 1,261 municipalities and 80 provinces, demonstrating that advanced diagnostics and AI-supported care can operate reliably at scale, even in remote and low-resource settings.

1Life’s integrated healthcare system brings diagnostics, consultations, and medicines together in a single community visit. By combining portable devices, cloud-based patient records, and AI-assisted workflows, the company has shortened what is usually a four-day primary care journey to about one hour. This shift has been especially impactful in rural and geographically isolated areas where access to diagnostic services has traditionally been limited.

Much of the one-million-patient count comes from community medical runs where residents receive essential diagnostics such as CBC, X-ray, ultrasound, ECG, urinalysis, and blood chemistry, followed by physician consultations and appropriate medicines. Patients also come from 1Life Primary Care Facilities, partner clinics using the 1Life Digital Community Healthcare System, and school and workplace health programs supported by local government units and national partners. In 2024 alone, the company served more than half a million Filipinos, with daily deployments of multiple medical teams that used AI tools to manage higher patient volumes without compromising quality.

At the core of these operations is the 1Life Digital Community Healthcare System, which links field missions, clinics, hospitals, pharmacies, and laboratories through a unified digital platform. This ecosystem is strengthened by DocMate AI, trained on hundreds of thousands of Filipino patient records, and the newly launched 1Life Health App, which gives users personal access to medical records, medicine reminders, and accurate health education. These tools generate real-time insights for partners and enable communities to shift from reactive, hospital-centric care to proactive early detection, a central goal of the country’s healthcare reforms.

The milestone also aligns with the Philippines’ goal of strengthening universal health coverage. As an accredited partner of DOH, PhilHealth, LGUs, and the DepEd YAKAP program, 1Life supports efforts to decongest hospitals by bringing early detection and primary care to the community level. Local leaders in remote and conflict-affected areas have reported greater participation in health programs and improved trust among residents who experienced, for the first time, fast and respectful care.

Niño Namoco, President of 1Life, Inc., highlighted the company’s mission to provide access to quality healthcare, leveraging innovative technology to prevent complications and streamline health processes for Filipinos, reflecting 1Life’s broader social impact:

“Reaching one million patients is a reminder that accessible healthcare can change lives when delivered with consistency, compassion, and the right technology. Every person we serve represents a family and a story, and we carry that responsibility with humility.” 

He added, “Our goal remains simple. 1Life is dedicated to making quality primary healthcare accessible to all, particularly the underserved communities. Central to our program is the early detection and prevention of diseases, which has enabled us to reach a million patients and further the pursuit of universal health equity. We are grateful to our partners and our team on the ground for making this possible. This milestone is only the beginning.”

1Life’s track record strengthens its position in the Philippine healthtech sector. The success of DocMate AI, the 1Life Health App, and the nationwide field deployments demonstrates that technology-supported primary care can operate reliably in diverse conditions across the country. This establishes 1Life as a trusted partner for groups seeking measurable and scalable healthcare solutions.

To learn more about 1Life, Inc., visit 1life.ph and facebook.com/1life.ph, or download the 1Life Health App on Google Play or the App Store.